Advanced Technology Ventures appeared to be the VC, which was created in 1979. The company was established in North America in United States. The main office of represented VC is situated in the Menlo Park.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Advanced Technology Ventures, startups are often financed by Trident Capital, New Enterprise Associates, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Norwest Venture Partners, U.S. Venture Partners (USVP), New Enterprise Associates. In the next rounds fund is usually obtained by DeNovo Ventures, U.S. Venture Partners (USVP), Trident Capital.
The fund is constantly included in 7-12 investment rounds annually. The real fund results show that this VC is 12 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Advanced Technology Ventures performs on 4 percentage points less the average number of lead investments. The high activity for fund was in 2000. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Advanced Technology Ventures the average startup value is 100-500 millions dollars. The top amount of exits for fund were in 2013.
We also calculated 5 valuable employees in our database.
Among the most popular fund investment industries, there are Information Technology, Internet. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Zeltiq Aesthetics, Acme Packet, Endurance International For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
Related Funds
Funds with similar focus
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Oasys Water | $4M | 03 Mar 2017 | Boston, Massachusetts, United States | ||
Cedexis | $22M | 26 Jan 2016 | Portland, Oregon, United States | ||
| $25M | 23 Sep 2014 | Irvine, California, United States | |||
Evergage | $4M | 21 May 2014 | Massachusetts, United States | ||
Catabasis Pharmaceuticals | $32M | 14 Nov 2013 | Cambridge, Massachusetts, United States | ||
Fuze | $26M | 15 Oct 2013 | Boston, Massachusetts, United States | ||
Second Genome | $6M | 05 Jun 2013 | San Francisco, California, United States | ||
Nuvaira | $10M | 08 Feb 2013 | Minneapolis, Minnesota, United States | ||
Calithera Biosciences | $2M | 28 Dec 2012 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Oasys Water | $4M | 03 Mar 2017 | Boston, Massachusetts, United States | ||
Cedexis | $22M | 26 Jan 2016 | Portland, Oregon, United States | ||
| $25M | 23 Sep 2014 | Irvine, California, United States | |||
Evergage | $4M | 21 May 2014 | Massachusetts, United States | ||
Catabasis Pharmaceuticals | $32M | 14 Nov 2013 | Cambridge, Massachusetts, United States | ||
Fuze | $26M | 15 Oct 2013 | Boston, Massachusetts, United States | ||
Second Genome | $6M | 05 Jun 2013 | San Francisco, California, United States | ||
Nuvaira | $10M | 08 Feb 2013 | Minneapolis, Minnesota, United States | ||
Calithera Biosciences | $2M | 28 Dec 2012 | South San Francisco, California, United States |
